NECAB3 and cancer: Interestingly, NECAB3, Mint3, and MT1-MMP were induced in three tumours (urothelial bladder cancer, papillary kidney carcinoma, liver hepatocellular carcinoma), implying that NECAB3-mediated HIF-1 activation might play some role in these cancers.